Ameritas Investment Partners’s Aravive, Inc. Common Stock ARAV Stock Holding History

Ameritas Investment Partners’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,074	Closed	-$7K	–	3272
2021 Q1	$7K	Hold	1,074	–	–	﹤0.01%	2959
2020 Q4	$6K	Hold	1,074	–	–	﹤0.01%	2951
2020 Q3	$5K	Hold	1,074	–	–	﹤0.01%	2991
2020 Q2	$13K	Buy	+1,074	New	+$12.7K	﹤0.01%	2597
2018 Q2	–	Sell	-477	Closed	-$5K	–	3075
2018 Q1	$5K	Hold	477	–	–	﹤0.01%	2865
2017 Q4	$6K	Hold	477	–	–	﹤0.01%	2854
2017 Q3	$54K	Hold	477	–	–	﹤0.01%	1856
2017 Q2	$50K	Buy	477 +84	+21%	+$9.02K	﹤0.01%	1906
2017 Q1	$50K	Buy	+393	New	+$41.4K	﹤0.01%	1843

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameritas Investment Partners's ARAV Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2021, closing a stake of 1,074 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in ARAV in Q1 2017 and held it in 9 quarters. The position peaked at $54K in Q3 2017. 49 funds tracked by Wall St. Rank hold ARAV as of Q2 2021.

Ameritas Investment Partners reported no remaining Aravive, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 1,074 Aravive, Inc. Common Stock shares in Q2 2021, an estimated $7K.
Ameritas Investment Partners first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Aravive, Inc. Common Stock position peaked at $54K in Q3 2017.
49 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.